Showing results (41-50 of 130) with videos related to
Sort By:
Pageof 13
Cell Reports|December 28, 2018
Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin InflammationTom Hartwig, Pascale Zwicky, Bettina Schreiner, et al.International Journal of Cancer|November 11, 2025
Characterization of long-term survivors with liver metastases from uveal melanoma diagnosed between 2005 and 2021Jona Laukhuf, Lisa Wiens, Gerd Grözinger, et al.Cancers|May 28, 2022
Genome-Wide Association Study Suggests the Variant rs7551288*A within the DHCR24 Gene Is Associated with Poor Overall Survival in Melanoma PatientsAnnette Pflugfelder, Xuan Ling Hilary Yong, Kasturee Jagirdar, et al.Immunity|January 19, 2010
Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functionsAhmed N Hegazy, Michael Peine, Caroline Helmstetter, et al.Cancers|December 10, 2021
Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical ChemistryLina María Serna-Higuita, Teresa Amaral, Andrea Forschner, et al.Cancer Immunology, Immunotherapy : CII|September 13, 2017
Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV diseaseStefan Diem, Omar Hasan Ali, Christoph J Ackermann, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2015
Protective efficacy of individual CD8+ T cell specificities in chronic viral infectionSusan Johnson, Andreas Bergthaler, Frederik Graw, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 29, 2012
Sensitive and rapid detection of ganciclovir resistance by PCR based MALDI-TOF analysisSamuel Zürcher, Catherine Mooser, Alexander Urs Lüthi, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 24, 2016
Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?Stefan Diem, Fabienne Keller, Reinhard Rüesch, et al.European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitorsOmar Hasan Ali, Fiamma Berner, David Bomze, et al.Pageof 13